Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Researchers have modified an oncolytic virus so that it blocks the protein TGF-beta, helping expose tumors to the immune system.

Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies: Molecular Therapy - Nucleic Acids

Cancers, Free Full-Text

Viruses, Free Full-Text

Cutting both ways: the innate immune response to oncolytic virotherapy

Cancers, Free Full-Text

Enhancing anti-tumour efficacy with immunotherapy combinations - The Lancet

Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme - Ahmed - 2023 - MedComm – Oncology - Wiley Online Library

Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution: Molecular Therapy - Oncolytics

Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virus: Molecular Therapy - Oncolytics

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways, Molecular Cancer

Oncolytic Viruses: Therapeutics With an Identity Crisis - eBioMedicine

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer - ScienceDirect

A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon: Molecular Therapy - Oncolytics

National Cancer Institute on Instagram: One of the most important findings in cancer research in the past two decades is that tumors can create force-field-like protection against the immune system. A new

Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer: Molecular Therapy - Oncolytics